Platelet suppressive therapy.
D001166:Arteriovenous Shunt, Surgical; D001241:Aspirin / Q000627:therapeutic use; D001792:Blood Platelets / Q000187:drug effects*; D002561:Cerebrovascular Disorders / Q000188:drug therapy; D002994:Clofibrate / Q000627:therapeutic use; D003327:Coronary Disease / Q000188:drug therapy; D004176:Dipyridamole / Q000627:therapeutic use; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006349:Heart Valve Diseases / Q000188:drug therapy; D006350:Heart Valve Prosthesis; D006801:Humans; D006886:Hydroxychloroquine / Q000627:therapeutic use; D013442:Sulfinpyrazone / Q000627:therapeutic use; D013924:Thrombophlebitis / Q000517:prevention & control; D013927:Thrombosis / Q000188:drug therapy
D005343:Fibrinolytic Agents; D006886:Hydroxychloroquine; D004176:Dipyridamole; D002994:Clofibrate; D001241:Aspirin; D013442:Sulfinpyrazone